Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Discovery Explains Why Influenza B Virus Exclusively Infects Humans

26.08.2011
Opens Door for Drugs to Fight Seasonal Epidemics Caused by Virus

Rutgers, University of Texas at Austin researchers determine three-dimensional structure of site on influenza B virus protein that suppresses human defenses to infection

Researchers at Rutgers University and the University of Texas at Austin have reported a discovery that could help scientists develop drugs to fight seasonal influenza epidemics caused by the common influenza B strain.

Their discovery also helps explain how influenza B is limited to humans, and why it cannot be as virulent as A strains that incorporate new genes from influenza viruses that infect other species. The devastating flu pandemic of 1918, the pandemics of 1968 and 1977, and the avian influenza that emerged in the middle of the last decade were caused by influenza A viruses. Understanding features of influenza B virus that limit it to humans will help scientists better understand how influenza A strains are able to cross species.

The researchers have determined the three-dimensional structure of a complex between an influenza B virus protein and one of its human protein targets, resulting in suppression of the cell’s natural defenses to the infection and paving the way for the virus to replicate efficiently.

Their findings are detailed in a paper published in the most recent issue of PNAS (Proceedings of the US National Academy of Sciences).

“Our study shows the basis by which non-structural protein 1 of influenza B, or NS1B, binds to a human host protein, immobilizing it to prevent it from fighting the virus,” said Gaetano Montelione, a lead author and professor of biochemistry and molecular biology, School of Arts and Sciences, at Rutgers. That human protein, known as interferon-stimulated gene 15 protein or ISG15, is an essential part of the defense mechanism that human cells use to protect themselves from viral infections. Chemicals that block the binding of NS1B to ISG15 may have antiviral potential against influenza B virus.

The study, led by professors Montelione and Robert Krug at the University of Texas at Austin, also reveals why NS1B cannot bind ISG15 molecules in other species, such as dogs or mice. Only human and non-human primate ISG15 proteins have a unique molecular sequence in a small part of the protein that makes it possible to bind to the NS1B protein. So far, influenza B virus has been found only in humans.

“The three-dimensional structure of the NS1B-ISG15 complex, which we determined using X-ray crystallography, has given us a clear understanding of the molecular basis for this species specificity,” said Krug, professor and chair of molecular genetics and microbiology.

“Flu infections continue to be a major health problem, with more effective drugs critically needed to treat infected individuals and control potential pandemics,” said Aaron Shatkin, director of the Center for Advanced Biotechnology and Medicine (CABM) at Rutgers and an eminent virologist. “This discovery opens new possibilities for achieving these very important goals.”

Participating in the study from Rutgers were Rongjin Guan, Li-Ching Ma and Brendan Amer, who along with Montelione are members of CABM and the Northeast Structural Genomics Consortium. They were joined by Paul Leonard of the Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, who is also a member of CABM and the Howard Hughes Medical Institute. Participating from the University of Texas at Austin were Haripriya Sridharan and Chen Zhao, who along with Krug are also members of the university’s Institute for Cellular and Molecular Biology.

Montelione is the Jerome and Lorraine Aresty Chair in Cancer Research at Rutgers, an endowed chair established to support Montelione’s research efforts in the general area of cancer biology research. Significantly, some of the human proteins that are targets of the influenza virus’s defense mechanisms, like ISG15, are also important in cancer biology. Krug is a Fellow of the Mr. And Mrs. Corbin J. Robertson, Sr. Regents Chair in Molecular Biology at the University of Texas at Austin.

The work was supported by grants from the Protein Structure Initiative (PSI-Biology) Program of the National Institutes of Health and its National Institute of General Medical Sciences, the National Institute of Allergy and Infectious Disease, and the Howard Hughes Medical Institute.

Media Contact: Carl Blesch
732-932-7084, ext. 616
E-mail: cblesch@ur.rutgers.edu
Contact: Lee Clippard
512-232-0675
E-mail: lclippard@mail.utexas.edu

Carl Blesch | EurekAlert!
Further information:
http://www.rutgers.edu

More articles from Life Sciences:

nachricht Repairing damaged hearts with self-healing heart cells
22.08.2017 | National University Health System

nachricht Biochemical 'fingerprints' reveal diabetes progression
22.08.2017 | Umea University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Cholesterol-lowering drugs may fight infectious disease

22.08.2017 | Health and Medicine

Meter-sized single-crystal graphene growth becomes possible

22.08.2017 | Materials Sciences

Repairing damaged hearts with self-healing heart cells

22.08.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>